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Abstract
Background: Uganda has suffered from a series of epidemics of Human African Trypanosomiasis (HAT), a tsetse
transmitted disease, also known as sleeping sickness. The area affected by acute Trypanosoma brucei rhodesiense
HAT (rHAT) has been expanding, driven by importation of infected cattle into regions previously free of the disease.
These regions are also affected by African Animal Trypanosomiasis (AAT) demanding a strategy for integrated
disease control.
Methods: In 2008, the Public Private Partnership, Stamp Out Sleeping Sickness (SOS) administered a single dose of
trypanocide to 31 486 head of cattle in 29 parishes in Dokolo and Kaberamaido districts. This study examines the
impact of this intervention on the prevalence of rHAT and AAT trypanosomes in cattle from villages that had (HAT
+ve) or had not (HAT-ve) experienced a recent case of rHAT. Cattle herds from 20 villages were sampled and screened
by PCR, pre-intervention and 6-months post-intervention, for the presence or absence of: Trypanosoma brucei s.l.;
human infective T. b. rhodesiense; Trypanosoma vivax; and Trypanosoma congolense savannah.
Results: Post-intervention, there was a significant decrease in the prevalence of T. brucei s.l. and the human infective
sub-species T. b. rhodesiense in village cattle across all 20 villages. The prevalence of T. b. rhodesiense was reduced from
2.4% to 0.74% (P < 0.0001), with the intervention showing greater impact in HAT-ve villages. The number of villages
containing cattle harbouring human infective parasites decreased from 15/20 to 8/20, with T. b. rhodesiense infection
mainly persisting within cattle in HAT+ve villages (six/eight). The proportion of T. brucei s.l. infections identified as
human infective T. b. rhodesiense decreased after the intervention from 8.3% (95% CI = 11.1–5.9%) to 4.1% (95% CI = 6.
8–2.3%). Villages that had experienced a recent human case (HAT+ve villages) showed a significantly higher prevalence
for AAT both pre- and post-intervention. For AAT the prevalence of T. vivax was significantly reduced from 5.9% to 0.
05% post-intervention while the prevalence of T. congolense increased from 8.0% to 12.2%.
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Conclusions: The intervention resulted in a significant decrease in the prevalence of T. brucei s.l., human infective
T. b. rhodesiense and T. vivax infection in village cattle herds. The proportion of T. brucei s.l. that were human infective,
decreased from 1:12 T. brucei s.l. infections before the intervention to 1:33 post-intervention. It is clearly more difficult to
eliminate T. b. rhodesiense from cattle in villages that have experienced a human case. Evidence of elevated levels of
AAT in livestock within village herds is a useful indicator of risk for rHAT in Uganda. Integrated veterinary and
medical surveillance is key to successful control of zoonotic rHAT.
Keywords: African animal trypanosomiasis (AAT), Human African trypanosomiasis (HAT), Sleeping sickness,
Trypanosma brucei rhodesiense HAT (rHAT), Uganda, T. b. brucei, T. b. rhodesiense
Multilingual abstracts
Please see Additional file 1 for translations of the ab-
stract into the five official working languages of the
United Nations.
Background
Human African Trypanosomiasis (HAT) or sleeping
sickness, comprises two distinct tsetse transmitted para-
sitic diseases, both of which are fatal if they are not
treated: chronic, Trypanosoma brucei gambiense HAT
(gHAT) and acute Trypanosoma brucei rhodesiense HAT
(rHAT) [1]. Uganda has active foci for both rHAT and
gHAT which have been geographically separated for more
than a century [1, 2]. gHAT lies in the northwest in districts
adjacent to South Sudan and is relatively stable [3] while
the area affected by rHAT, originally restricted to the shores
of Lake Victoria [4] began expanding from the mid-1980s.
An rHAT epidemic began in Tororo district in the mid-
1980s spreading to Butaleja and Busia districts [5–7]
spreading to Soroti and Serere districts in 2000 [7, 8] and
subsequently to Kaberamaido and Dokolo districts by 2004
[9, 10]. By 2005, the areas affected by gHAT and rHAT
were only 150 km apart [11].
The causal agent of rHAT,T. b. rhodesiense, co-exists in a
range of non-human hosts [12] with a suite of other try-
panosomes that cause African Animal Trypanosomiasis
(AAT). A series of studies showed that cattle in Uganda
carried human infective T. b. rhodesiense [6, 7, 9] and that
movements of infected cattle from districts within the
rHAT focus to rHAT free districts [8, 13] were responsible
for the spread of rHAT in Uganda. The epidemic in Soroti
was directly linked to importation of cattle through
Brooks Corner cattle market [8].
Both HAT and AAT are major priorities for Uganda [14,
15] with approximately one-third of the national herd at risk
from AAT [15], with serious economic losses [16]. Infection
with T. b. rhodesiense in indigenous cattle is largely asymp-
tomatic; livestock in rural areas of Uganda are not routinely
treated unless they show co-infection with T. congolense or
T. vivax. Cattle are long-term investments and untreated in-
fected animals comprise a persistent zoonotic reservoir of
rHAT parasites posing a threat to human health.
The expansion of the rHAT focus poses a significant
health risk (Fig. 1) and convergence of the gHAT and
rHAT foci would compromise existing approaches for
diagnosis and treatment [17]. T. b. rhodesiense HAT is sig-
nificantly under-reported [18] and identification of human
cases remains a challenge to the health system [19]. Con-
trolling rHAT requires veterinary intervention [20]. A sin-
gle trypanocidal intervention, targeted to cattle in Kamuli
and Soroti districts, at high risk for rHAT in 2002 reduced
the prevalence of T. b. brucei s.l. and T. b. rhodesiense and
resulted in a significant decrease in human rHAT cases
[21] suggesting that if sufficient head of cattle were
treated, rHAT transmission could be stopped [22]. In
2006, a Public Private Partnership, Stamp Out Sleeping
Sickness (SOS) [23], aimed to remove the reservoir of T.
b. rhodesiense in Soroti, Dokolo, Lira, Apac and Kabera-
maido districts by mass treating cattle [24].
Here we examine the impact of mass cattle trypanocidal
intervention on the parasite burden (T. brucei s.l., T. vivax
and T. congolense and human infective T. b. rhodesiense
parasites) in cattle within the SOS intervention zone, at
village level, examining villages that had and had not pre-
viously experienced a human case of rHAT.
Methods
Description of the study area
The study area comprised Kaberamaido and Dokolo districts
(in the Eastern and Northern regions respectively) in
Uganda, which have been affected by rHAT since 2004. The
districts border the northern shore of Lake Kyoga with a
combined area of approximately 2 467 km2 and a human
population of approximately 261 000 [25]. The main eco-
nomic activities within the study area are agriculture and
fishing, with the majority of the population engaged in sub-
sistence farming [26]. The first cases of rHAT were reported
in Kaberamaido and Dokolo districts in 2004 and the con-
tinued presentation of new cases indicates active transmis-
sion in both districts. A mass chemotherapuetic intervention
was undertaken in cattle, in these districts in 2006, in an
attempt to prevent the northwards spread of rHAT [24]. Ac-
cording to the livestock census undertaken in 2008, Dokolo
had 58 902 cattle and Kaberamaido 76 109 cattle (Table 1).
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Fig. 1 Districts of Uganda affected by T. b. rhodesiense HAT (rHAT) and T. b. gambiense HAT (gHAT). Study districts, Dokolo and Kaberamaido,
are indicated
Table 1 Demographic data for Dokolo and Kaberamaido districts
District Human population
(2002 census)
Cattle population
(2008 census)
Land area (km2)
(1995 census)
Estimated cattle
density (km2)
Dokolo 129 385 58 902 1 113 53
Kaberamaido 131 650 76 109 1 354 56
N.B. Figures derived from the Ugandan Bureau of Statistics. Land mass for Kaberamaido excludes open water areas (269 km2 for) but includes seasonal and
permanent wetlands (144 km2). Land/water area data for Dokolo district was not available, but this district has relatively small open water and wetland areas
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Description of the intervention
Between April and May 2008, due to the persistence of
rHAT cases in parishes lying on the border between
Dokolo and Kabaramiado [10, 27], a further interven-
tion, comprising a single dose of trypanocide, was given
to 31 486 cattle across 29 rHAT affected parishes
(Table 2). All villages in the districts were geo-
referenced using hand held global positioning systems
prior to the intervention (GPS: Garmin, E-trex venture)
[26]. Intervention sites were selected at parish level (be-
tween 3-10 villages); an average village had less than 100
households with between 30 and 50% of households
owning cattle, typically small herds of 3–10 cattle al-
though some larger herds of 50–100 cattle were present
[28]. All available village cattle were injected with a sin-
gle dose of Veriben (diminazene aceturate - Ceva Santé
Animale) at 7.5 mg/kg; at the same time a single applica-
tion of the insecticide Vectocid (Ceva Santé Animale) was
applied to the legs and belly [29–31]. Treatment coverage
data was obtained from estimates based on the total num-
ber of cattle treated in the parishes under the SOS inter-
vention and from farmer reporting of intervention status
of cattle sampled 6 months after intervention.
Study design
To examine the parasite dynamics before and after inter-
vention, two groups of villages were selected: villages
that had experienced a case of human rHAT in the pre-
vious 6 months (rHAT+ve villages) and those that had
never reported a case (rHAT-ve villages). Records de-
tailing all rHAT patients between January and June
2007 were obtained from the two health centres
established for treatment of rHAT in Dokolo and
Kaberamaido: Lwala health centre in Kaberamaido
district and Serere health centres in Soroti district
[18]. Cases were cross-referenced to the geo-
referenced village data to classify all villages into two
groups: case villages and no-case villages. A case vil-
lage (rHAT+ve village) was defined as having one or
more rHAT cases diagnosed in the 6 month period
January – June 2007. Twenty villages were randomly
selected to monitor the impact of the intervention: 10
rHAT+ve villages that had reported a rHAT case between
January – June 2007 and 10 that had never reported a case
(HAT-ve villages). Figure 2 shows the location of all study
villages and the intervention sites. The village HAT case
status is shown in Fig. 3 which also indicates the location
of the HAT treatment centre.
Sample size calculation
The required sample size was based on the requirement
for comparing two proportions (rHAT case vs. non
rHAT case villages) [32], with adjustment for cluster
sampling [33] at the village level. An estimated T. brucei
s.l. prevalence of 20% was used, alongside an inter-
cluster variance (Vc) of 0.013 [34] to allow for a differ-
ences in trypanosome prevalence to be detected at 95%
confidence and 80% power [32]. This called for a
Table 2 Cattle treated March to April 2008 in Dokolo and Kaberamaido districts (percentage of the estimated total cattle population
by parish)
Dokolo district Kaberamaido district
Parish Estimated population Number treated % Parish Estimated population Number treated %
Anwangi/Amwoma 2 503 1 962 78 Oguolo 1 206 1 998 166
Aneralibi 1 252 1 044 83 Amoru 840 3 036 361
Iguli 1 050 867 83 Kalaki 1 554 903 58
Adwila 1 638 660 40 Kadie 752 1 554 207
Angwenya 400 1 253 313 Opiltok 162 1 701 1 050
Akurolango 1 242 2 117 171 Lwala 561 909 162
Angwecibange/Atur 882 656 75 Olelai 1 311 1 538 117
Alwithmac 800 760 95 Oryamo 584 1 261 216
Adagmon 1 000 488 49 Abalang 1 500 701 47
Awiri 513 578 127 Acanpi 790 420 53
Aderolongo 529 435 82 Kamuk 1 503 783 52
Okile 972 2 466 254
Abal-kweru 1 037 993 96
Kaberamaido 873 188 22
Plantau 1 804 1 051 58
Katinge 1 470 1 164 79
TOTAL 11 809 10 820 91.6% TOTAL 16 919 20 666 122%
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minimum sample number of 67 individual cattle per
cluster, across 20 village clusters (1 340). Cattle were sys-
tematically sampled by order of presentation at each vil-
lage sampling site, up to a maximum of 100 animals per
village, to maintain sufficient sample size of cattle from
rHAT case and non-rHAT case villages overall, and to
compensate for villages with fewer than 67 cattle.
Sample collection
Samples of blood (100 μl) were taken from the ear vein
of cattle in the rHAT+ve (case) villages and rHAT+ve (no
case) villages, before (April – May 2008) and 6 months
after intervention (October 2008). In total 3 549 cattle
were sampled: 1 658 before intervention and 1 891 after
6 months intervention. Before taking blood samples, the
livestock owner was asked whether the animal had been
treated during the mass intervention.
One hundred microliters of blood was drawn from
the ear capillary using a lancet, collected into two
50 μl capillary tubes and spotted on a FTA™ card
(Whatman, Maidstone, Kent, UK). Cards were air
dried at room temperature for 24 h and stored in
multi-barrier pouches with desiccant (Whatman, UK).
Laboratory analysis
Samples were analysed by PCR to identify all trypano-
some species and subspecies present. Five 3 mm discs
were punched from each blood sample and processed as
Fig. 2 Location of study village and intervention (treatment sites) in Dokolo and Kaberamaido districts
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previously described [35–37]. Discs were washed four
times, twice with FTA purification reagent and twice
with TE buffer, before being air dried and then heated at
90 °C for 30 min suspended in 5% (w/v) Chelex solution.
Five microliters of eluted sample solution, was used to
seed all PCR reactions. Previously published species spe-
cific primers were used to detect T. brucei s.l., T. vivax,
and T. congolense savannah, in three separate PCR reac-
tions [35–37]. Samples positive for T. brucei s.l. were
further tested for T. b. rhodesiense using a multiplex
PCR to discriminate T. b. brucei and T. b. rhodesiense
[38]. Standard PCR amplifications for all reactions were
carried out in 25 μl mixtures; reaction conditions, pri-
mer sequences and cycling conditions were as previously
published [35–37]. One positive control [genomic de-
oxyribonucleic acid (DNA)] and one negative control
(extract from blank FTA™ disc) were run with each reac-
tion. PCR products were resolved via electrophoresis on
1.5% agarose gels using GelRed DNA stain and run at
100v for a minimum of 45 min in the presence of a mo-
lecular marker, until band size could be easily deter-
mined. PCR products were visualised and documented
with a BioRad GelDock™ imaging system.
Statistical analysis
The prevalence of T. brucei s.l., T. b. rhodesiense, T. vivax
and T. congolense savannah trypanosome infection detected
by PCR were expressed as a percentage, and exact binomial
95% confidence intervals were computed (R, version 2.0.1).
Fisher’s Exact test was used to compare trypanosome preva-
lence in rHAT+ve and rHAT–ve villages and between the
pre- and 6 months post-intervention sampling.
Results
One thousand six hundred and fifty-eight cattle blood
samples were obtained before intervention from the 20
village sites; 854 from animals in HAT+ve villages and
804 from cattle in HAT–ve villages. Of these, 642 sam-
ples were positive for one or more species of trypano-
some; 362 from HAT+ve villages (prevalence 42.4%, 95%
CI = 45.8–39.1%) and 280 were from HAT–ve villages
(prevalence 34.8%, 95% CI = 38.2–31.5%). The preva-
lence of cattle trypanosomiasis (AAT) was significantly
higher in HAT+ve villages (P < 0.001).
Six months post-intervention, 1 891 cattle blood sam-
ples were taken from the same 20 villages; 956 from
HAT+ve villages and 935 from HAT–ve villages. Of these
Fig. 3 Location of HAT+ve and HAT -ve study villages in Dokolo and Kaberamaido districts
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509 cattle were positive for one or more species of tryp-
anosome; 266 (prevalence 27.8%, 95% CI = 30.8–25.0%)
were from HAT+ve villages and 243 (prevalence 26.0%,
95% CI = 28.9–23.2%) from HAT–ve villages (see Fig. 4).
T. brucei s. l
T. brucei s.l. was the most common species detected
both before and after intervention (Fig. 4). T. brucei s.l.
prevalence varied from 15.6 to 53.0% between villages.
The prevalence of T. brucei s.l. was significantly higher in
HAT+ve villages than in HAT–ve villages pre-intervention
(P = 0.002) and post-intervention (P = 0.008).
Across all 20 villages, the prevalence of T. brucei s.l.
was significantly lower 6 months after the intervention,
irrespective of village HAT status. For HAT+ve villages,
the prevalence of T. brucei s.l. in cattle was 31.7% (271/
854 95% CI = 35.0–28.6%) pre-intervention and signifi-
cantly lower, 20.4% (195/956 95% CI = 23.1–17.9%),
post-intervention (P < 0.0001). In cattle from villages de-
fined as HAT–ve, T. brucei s.l. prevalence was 25.0%
(201/804 95% CI = 28.1–22.0%) pre-intervention and sig-
nificantly lower, 15.7% (147/935 95% CI = 18.2–13.4%), 6
months post-intervention (P < 0.0001).
T. b. rhodesiense
There was a reduction in the prevalence of human infect-
ive T. b. rhodesiense in cattle 6 months post intervention
in both HAT+ve and HAT–ve villages. Across the 20 study
villages the prevalence of human infective T. b. rhode-
siense in cattle was reduced 3-fold, from 2.4% (39/1658)
pre-intervention to 0.74% 6 months post-intervention (14/
1891). Within the HAT+ve villages, pre-intervention, the
prevalence of T. b. rhodesiense, in cattle was 2.5% (21/854,
95% CI = 3.7–1.5%). This was halved to 1.26% (12/956,
95% CI = 2.2–0.7%, P = 0.077) post-intervention. In cattle
from the HAT–ve villages the prevalence of T. b. rhodesiense
was 2.2% (18/804, 95% CI = 3.5–1.3%) pre-intervention,
and this was significantly decreased, by more than 10-
fold, post-intervention to 0.2% (2/935, 95% CI = 0.8–
0.0%, P < 0.0001).
The intervention also impacted in the proportion of
human infective T. b. rhodesiense within the population
of circulating T. brucei s.l. in cattle (Fig. 5). Critically,
the proportion of T. b. brucei that was T. b. rhodesiense
(human infective) decreased after intervention. Prior to
the intervention in rHAT+ve and rHAT–ve villages com-
bined 8.3% (39/472, 95% CI = 11.1–5.9%) of circulating
T. brucei s.l. were human infective; post-intervention
this reduced to 4.1%, (14/342, 95% CI = 6.8–2.3%). Prior
to the intervention, cattle in 15 of the 20 study villages
had T. b. rhodesiense prevalences ranging from 1 to 5%.
T. b. rhodesiense was not detected in any cattle in three
HAT+ve villages and two HAT–ve villages. Six months
post-intervention, only eight of the 20 study villages con-
tained T. b. rhodesiense positive cattle; 75% (6/8) of these
were from HAT+ve villages. The locations of villages har-
bouring cattle infected with T. b. rhodesiense before and
after intervention are shown in Fig. 6.
AAT
Prior to the intervention, the prevalence of T. vivax in
HAT+ve village cattle was 5.7% (49/854, 95% CI = 7.5–
4.3%) and 6.1% (49/804, 95% CI = 8.0–4.5%) in HAT–ve
villages. At 6 months post-intervention, no T. vivax in-
fected cattle were found in the HAT+ve villages (0/956,
95% CI = 0.4–0%, P < 0.0001) and only a single case of T.
vivax in HAT–ve villages was observed (0.1%; 1/935, 95%
CI = 0.6–0.0%, P < 0.0001). This is a significant reduction
in prevalence, from 6% (98/1658) pre-intervention to
0.05% (1/1891) 6 months after intervention. There was
Fig. 4 Prevalence of trypanosome species and sub-species (T. brucei s.l., T. b. rhodesiense, T. congolense and T. vivax) pre- and 6-months post-intervention
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no significant difference in the prevalence of T. vivax in
cattle from villages defined as HAT+ve or HAT–ve either
before or after intervention.
Infection in cattle with T. congolense savannah was sig-
nificantly greater than T. vivax, both before and after inter-
vention (P = 0.0043) (Table 3). In total, the prevalence of T.
congolense savannah increased from 8% (133/1 658) to
12.2% (231/1891). In cattle from HAT+ve villages there
was no significant difference in the prevalence of T. con-
golense savannah before (9.7%; 83/854, 95% CI = 11.9–
7.8%) or after intervention (11.3%; 108/956, 95% CI =
13.5–9.4%) (P = 0.2842). In cattle from HAT–ve villages
the prevalence of T. congolense savannah before inter-
vention was 6.7% (54/804, 95% CI = 8.7–5.1%), signifi-
cantly lower than in HAT+ve villages (P = 0.0319). Six
months post-intervention, the prevalence of T. congolense
Fig. 5 Proportion of T. brucei s.l. that are T. b. rhodesiense (infective
for humans) pre- and post-intervention in HAT+ve and HAT-ve study
villages (95% confidence intervals indicated)
Fig. 6 Distribution of villages harbouring T. b. rhodesiense infected cattle pre- and 6-months post-intervention
Table 3 Prevalence of Trypansoma vivax and Trypanosoma
congolense savannah species pathogenic for cattle, in HAT+ve
and HAT–ve villages before and after intervention
Village HAT
status
Prevalence T.
vivax
Prevalence T. congolense
savannah
Pre-intervention HAT+ve 5.7% (7.51–4.27%) 9.7% (11.91–7.82%)
HAT+ve 6.1% (7.98–4.54%) 6.7% (8.67–5.09%)
Total 5.9% (7.16–4.87%) 8.0% (9.43–6.81%)
Six months post-
intervention
HAT+ve 0% (0.39–0%) 11.3% (13.48–9.36%)
HAT–ve 0.1% (0.41–0.01%) 13.2% (15.48–11.13)
Total 0.05% (0.30–0%) 12.2% (13.77–10.81%)
Brackets indicate 95% confidence intervals
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savannah of 13.2% significantly increased (123/935, 95%
CI = 15.5–11.1%, P < 0.0001).
Intervention coverage
Mathematical modelling estimated that to interrupt T. b.
rhodesiense transmission, where cattle were the principal
reservoir of T. b. rhodesiense, required treatment of 86%
of the cattle population [22]. Between April and May
2008, SOS reported administering a trypanocide to 31,
486 head of cattle across 29 parishes in Dokolo and
Kaberamaido. Estimations of intervention coverage were
based on the total number of cattle treated, the 2008
livestock census data and farmer based reporting 6
months post-intervention. The livestock census was
based on household survey data collected at a fixed
number of points within each district throughout
Uganda; this was modelled to parish level, based on
demographic trends and other data, by district-level
staff. The exact methodology employed is uncertain, and
the parish level data are of variable quality. The 2008
census data were conservatively inflated by 20% on the
advice of the District Veterinary Officers in Dokolo and
Kaberamaido to allow for population growth and im-
portation from other districts as part of national restock-
ing programs as well as trade (Table 2).
In Dokolo district, 10 820 out of an estimated 11, 809
head of cattle from 13 parishes were treated
(91.6%) – 20% of the total estimated cattle population of
Dokolo district (58 902). In Kaberamaido, 20 666 cattle
were treated from 16 parishes with an estimated cattle
population of 16 919 head, giving estimated coverage of
122% or 27% of the total cattle population in the district
(76 109 head). Of the 29 parishes, eight showed coverage
below 60% while 11 parishes showed coverage >100%;
six parishes had more than 200% estimated coverage.
Six months after the intervention, livestock-keepers in
the 20 study villages were asked to report whether their
animals had participated in the intervention. According
to the livestock-keepers, 55.2% (1 044/1891) of the cattle
sampled 6 months after the intervention had participated
in the intervention (Table 4). Fewer animals, 51% (486/
956), were reported to have participated in the HAT+ve
villages than in the HAT-ve villages, 59.7% (558/935).
Intervention coverage impacted on identification of
Trypanosoma infection by PCR (Table 4). Of the 342
animals found positive for T. brucei s.l., 47% at the 6
month post-intervention sampling were from cattle that
had not participated in the intervention (162/342).
Within the HAT+ve villages 52% (101/195) of the animals
found positive for T. brucei, had not participated in the
intervention. Of the 12T. b. rhodesiense infections identi-
fied in HAT+ve villages, 66% (8/12) were observed in cattle
reported not to have particpated in the intervention . Of
the 231T. congolense infections identified 37% were from
animals reported not to have participated in the interven-
tion and 63% from those reported to have particpated.
Discussion
Microscopy consistently underestimates the prevalence
trypanosomes in livestock [38, 39], so the use of sensitive
and specific ‘field friendly’ diagnostic tools are key to
our understanding of the epidemiology of bovine and
zoonotic trypanosomiasis [39]. Cattle have been shown
to play a major role in the epidemiology of rHAT in
Uganda [6–9, 21, 33]. This is one of the first studies to
use molecular tools to evaluate large-scale field interven-
tions targeted at T. b. rhodesiense, the causal agent of
rHAT, in cattle - the principal animal reservoir. Previous
studies have shown the importance of eliminating the
reservoir of human infective T. b. rhodesiense parasites
from domestic cattle to prevent human infection [21, 32].
Across the 20 randomly selected villages within the
intervention zone we observed a significant reduction of
T. b. rhodesiense in cattle 6 months after the interven-
tion (from 2.40 to 0.74%), a 10-fold decrease in preva-
lence of T. b. rhodesiense in HAT–ve villages compared
to a 50% reduction of T. b. rhodesiense in HAT+ve vil-
lages. The number of villages with T. b. rhodesiense
Table 4 Trypanosoma infection and intervention participation status of cattle sampled at 6 months post-intervention as reported by
livestock-keepers
Village HAT status Intervention participation Cattle sampled (n) TBSL + (n) % TBSL + SRA + (n) % SRA + TV + (n) % TV + TC + (n) % TC +
HAT + villages 956 195 20.4 12 1.3 0 0 108 11.3
Unknown 32 5 15.6 0 0 0 0 3 9.4
Intervention 486 89 18.3 4 0.8 0 0 56 11.5
No intervention 438 101 23.1 8 1.8 0 0 49 11.2
HAT - villages 935 147 15.7 2 0.2 1 0.1 123 13.2
Unknown 27 0 0 0 0 0 0 4 14.8
Intervention 558 86 15.4 1 0.2 1 0.2 83 14.9
No intervention 350 61 17.4 1 0.3 0 0 36 10.3
NB: TBSL + − sample positive for T. brucei s.l; SRA + sample positive for human infective T. b. rhodesiense; TV + sample positive for T. vivax; TC + sample positive for
T. congolense savannah
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infected cattle fell from 15 to eight villages post-
treatment; most T. b. rhodesiense infected cattle post-
intervention were from villages that had a case of human
rHAT (six of the eight infected villages). This emphasises
the focal nature of rHAT [33, 40] suggesting that once
T. b. rhodesiense is established in a village, spilling over
from cattle into humans, eliminating the cattle reservoir
of T. b. rhodesiense in the village becomes more difficult.
HAT transmission is influenced by many factors, in-
cluding tsetse population density, tsetse susceptibility
[41] and proximity to around a central point such as a
market, watering point or swampland [8, 10, 40]. In this
study villages that had experienced a case of rHAT also
showed a significantly higher prevalence of T. brucei s.l.
and T. congolense in the village cattle than those that
had not had a case of rHAT, further evidence of a link
between AAT and T. b. rhodesiense HAT. Conditions for
transmission of all species of trypanosome appeared
more favourable in HAT+ve villages.
T. vivax all but disappeared across the study villages
post-intervention, but the prevalence of T. congolense in-
creased (although a large proportion of infected animals
had not participated in the intervention). Drug resistance
in cattle has been reported for T. congolense in parts of
Ethiopia [42] and Burkina Faso [43] but this has not been
reported in Uganda where T. congolense infection is rarely
reported or treated. Eliminating T. vivax and reducing T.
brucei s.l. in cattle may simply offer opportunities for T.
congolense to establish in these animals [44].
To interrupt T. b. rhodesiense transmission, where cat-
tle are the principal reservoir of T. b. rhodesiense, it is
calculated that 86% of the cattle population must be
treated [22]. The discrepancy between the coverage esti-
mates calculated from the livestock census data (91.3%)
and the lower estimates obtained provided from the
livestock-keepers (55.2%) show the difficulties of calcu-
lating coverage in the absence of robust and verifiable
village and parish cattle numbers; true coverage probably
lay somewhere between the two.
In Dokolo, cattle were treated in 13 of 33 parishes in the
district, or 39% of the district; coverage was estimated at
20% of the district cattle. Likewise, for Kaberamaido, the
mass intervention covered 50% of the district (16 of 32
parishes) but using, 2008 livestock census data, only 27%
of the district cattle population are estimated to have been
treated. The parishes treated during the mass intervention
had relatively low cattle populations compared to other
areas of the district.
Accurate information about the number of cattle
owned by individuals and households in this region is
difficult to obtain. Extensive cattle rustling in the late
1980s decimated livestock in the region and the Lango
and Teso economy [45] and cattle restocking projects
[46] were ongoing during 2008 when this intervention
took place [13]. Villagers may answer questions about
donor-led interventions in ways that take into account
how their answers will influence future benefits [47] and
it is likely that a proportion of livestock-keepers misre-
presented the treatment status of their cattle in the hope
that their herd would be re-treated.
Conclusions
Treatment of cattle produced a significant decrease in the
prevalence of T. brucei s.l., human infective T. b. rhode-
siense and T. vivax infection in village cattle herds and im-
pacted on the proportion of T. brucei s.l. that were human
infective: from 1:12 human infective T. brucei s.l. before
the intervention to 1:33 post-intervention.
The observation that is more difficult to remove T. b.
rhodesiense from villages that have experienced a rHAT
case, makes a strong case for improved information shar-
ing between human health providers, animal health pro-
viders and the community. The prevalence of AAT in
villages can serve as an additional indicator of human
health risk in these communities, alerting medical services
to survey human populations. Incorporating participatory
research in conjunction with traditional disease modelling
approaches could lead to improved disease control [48].
To prevent the continued migration of rHAT, point of
sale trypanocide treatments should be applied for all
inter-district cattle movements and interventions that
target rHAT and AAT should be scaled up in all rHAT
affected districts. Interventions that additionally target
tick-borne diseases are welcomed by local communities
[45], where trypanosomiasis and tick-borne diseases re-
duce draft cattle output by 21% and household income
from the use of oxen (estimated at $245 USD annually)
by 32% [49]. Appropriate scaled application of trypanoci-
dal drugs, followed by routine application of veterinary
pyrethroids to prevent re-infection and manage tick in-
festation, offer a sustainable solution for zoonotic HAT,
AAT and tick-borne disease control [29, 31, 49, 50] offer-
ing a win-win for human and animal health.
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